Consider a subject entered on a clinicaltrial in which the major endpoint is a time metric such as deathor time to reach a well defined event. During the observationalperiod the subject may experience an intermediate clinical event.The intermediate clinical event may induce a change in the survivaldistribution. We consider models for the one and two sample problem.The model for the one sample problem enables one to test if theoccurrence of the intermediate event changed the survival distribution.This models provides a way of carrying out non-randomized clinicaltrial to determine if a therapy has benefit. The two sample problemconsiders testing if the probability distributions, with andwithout an intermediate event, are the same. Statistical...
Background Data from clinical trials where the endpoint is a single survival time are readily analys...
Adaptive treatment strategies closely mimic the reality of a physician's prescription process where ...
IntroductionThis study considers the prediction of the time until two survival outcomes have both oc...
Treatment of complex diseases such as cancer, HIV, leukemia and depression usually follows complex t...
Comparing the survival times among two groups is a common problem in time-to-event analysis, for exa...
A common problem that is encountered in medical applications is the overall homogeneity of survival ...
The conventional approach to comparing a new treatment with a standard therapy is often based on a s...
Medical time-to-event studies frequently include two groups of patients: those who will not experien...
Sequentially randomized designs are becoming common in biomedical research, particularlyin clinical ...
Survival analysis is a branch of statistics and biostatistics that studies and compares the survival...
Medical time-to-event studies frequently include two groups of patients: those who will not experien...
Sequentially randomized designs are becoming common in biomedical research, particularlyin clinical ...
We propose to use mixture survival models to establish the efJicacy of the trial treatment. In parti...
It is increasingly common in clinical trials to design studies for which more than one primary outco...
<div><p>A common problem that is encountered in medical applications is the overall homogeneity of s...
Background Data from clinical trials where the endpoint is a single survival time are readily analys...
Adaptive treatment strategies closely mimic the reality of a physician's prescription process where ...
IntroductionThis study considers the prediction of the time until two survival outcomes have both oc...
Treatment of complex diseases such as cancer, HIV, leukemia and depression usually follows complex t...
Comparing the survival times among two groups is a common problem in time-to-event analysis, for exa...
A common problem that is encountered in medical applications is the overall homogeneity of survival ...
The conventional approach to comparing a new treatment with a standard therapy is often based on a s...
Medical time-to-event studies frequently include two groups of patients: those who will not experien...
Sequentially randomized designs are becoming common in biomedical research, particularlyin clinical ...
Survival analysis is a branch of statistics and biostatistics that studies and compares the survival...
Medical time-to-event studies frequently include two groups of patients: those who will not experien...
Sequentially randomized designs are becoming common in biomedical research, particularlyin clinical ...
We propose to use mixture survival models to establish the efJicacy of the trial treatment. In parti...
It is increasingly common in clinical trials to design studies for which more than one primary outco...
<div><p>A common problem that is encountered in medical applications is the overall homogeneity of s...
Background Data from clinical trials where the endpoint is a single survival time are readily analys...
Adaptive treatment strategies closely mimic the reality of a physician's prescription process where ...
IntroductionThis study considers the prediction of the time until two survival outcomes have both oc...